scispace - formally typeset
J

Jiajia Xue

Researcher at Beijing University of Chemical Technology

Publications -  80
Citations -  5830

Jiajia Xue is an academic researcher from Beijing University of Chemical Technology. The author has contributed to research in topics: Nanofiber & Medicine. The author has an hindex of 22, co-authored 57 publications receiving 3220 citations. Previous affiliations of Jiajia Xue include Georgia Institute of Technology & The Wallace H. Coulter Department of Biomedical Engineering.

Papers
More filters
Journal ArticleDOI

Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications

TL;DR: This work aims to provide a comprehensive overview of electrospun nanofibers, including the principle, methods, materials, and applications, and highlights the most relevant and recent advances related to the applications by focusing on the most representative examples.
Journal ArticleDOI

Electrospun Nanofibers: New Concepts, Materials, and Applications

TL;DR: The unique capabilities of electrospun nanofibers as porous supports for heterogeneous catalysis and as functional scaffolds for tissue regeneration are demonstrated by concentrating on some of the recent results.
Journal ArticleDOI

Drug loaded homogeneous electrospun PCL/gelatin hybrid nanofiber structures for anti-infective tissue regeneration membranes

TL;DR: The potential for using MNA-loaded PCL/gelatin electrospun membranes as anti-infective GTR/GBR membranes to optimize clinical application of GTR-GBR strategies is indicated.
Journal ArticleDOI

Electrospun microfiber membranes embedded with drug-loaded clay nanotubes for sustained antimicrobial protection.

TL;DR: The sustained release of metronidazole from the membranes prevented the colonization of anaerobic Fusobacteria, while eukaryotic cells could still adhere to and proliferate on the drug-loaded composite membranes.
Journal ArticleDOI

A Hybrid Nanomaterial for the Controlled Generation of Free Radicals and Oxidative Destruction of Hypoxic Cancer Cells.

TL;DR: A novel strategy that employs oxygen-independent free radicals generated from a polymerization initiator for eradicating cancer cells by inducing apoptosis in hypoxic cancer cells is introduced.